- Home
- AMPH
as 07-26-2024 4:00pm EST
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | RANCHO CUCAMONGA |
| Market Cap: | 1.8B | IPO Year: | 2014 |
| Target Price: | $64.67 | AVG Volume (30 days): | 408.0K |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.90 | EPS Growth: | 62.92 |
| 52 Week Low/High: | $36.56 - $67.66 | Next Earning Date: | 08-06-2024 |
| Revenue: | $676,209,000 | Revenue Growth: | 30.38% |
| Revenue Growth (this year): | 19.05% | Revenue Growth (next year): | 6.08% |
Stock Insider Trading Activity of Amphastar Pharmaceuticals Inc. (AMPH)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| PETERS WILLIAM J | AMPH | CFO, EVP & TREASURER | Jun 27 '24 | Sell | $41.29 | 635 | $26,222.07 | 94,103 | SEC Form 4 |
| PETERS WILLIAM J | AMPH | CFO, EVP & TREASURER | Jun 27 '24 | Sell | $40.85 | 2,961 | $120,947.08 | 94,738 | SEC Form 4 |
| Petersen Floyd F. | AMPH | Director | Jun 10 '24 | Sell | $41.40 | 3,000 | $124,200.00 | 78,409 | SEC Form 4 |
| Petersen Floyd F. | AMPH | Director | Jun 3 '24 | Sell | $42.65 | 500 | $21,325.90 | 78,333 | SEC Form 4 |
| Petersen Floyd F. | AMPH | Director | May 1 '24 | Sell | $41.67 | 500 | $20,836.95 | 78,833 | SEC Form 4 |
| Petersen Floyd F. | AMPH | Director | Apr 1 '24 | Sell | $43.43 | 500 | $21,714.15 | 79,333 | SEC Form 4 |
| PETERS WILLIAM J | AMPH | CFO, EVP & TREASURER | Mar 6 '24 | Sell | $46.30 | 13,404 | $620,539.52 | 116,222 | SEC Form 4 |
| PETERS WILLIAM J | AMPH | CFO, EVP & TREASURER | Mar 6 '24 | Sell | $46.98 | 4,681 | $219,895.59 | 111,541 | SEC Form 4 |
| PETERS WILLIAM J | AMPH | CFO, EVP & TREASURER | Mar 6 '24 | Sell | $48.00 | 51 | $2,448.00 | 111,490 | SEC Form 4 |
| ZASLOFF MICHAEL A | AMPH | Director | Mar 5 '24 | Sell | $47.06 | 9,389 | $441,870.75 | 24,437 | SEC Form 4 |
| ZASLOFF MICHAEL A | AMPH | Director | Mar 5 '24 | Sell | $47.53 | 3,111 | $147,853.39 | 21,326 | SEC Form 4 |
| Petersen Floyd F. | AMPH | Director | Mar 1 '24 | Sell | $45.60 | 451 | $20,567.45 | 79,882 | SEC Form 4 |
| Petersen Floyd F. | AMPH | Director | Mar 1 '24 | Sell | $46.53 | 49 | $2,279.89 | 79,833 | SEC Form 4 |
| Petersen Floyd F. | AMPH | Director | Feb 1 '24 | Sell | $53.07 | 474 | $25,153.76 | 80,359 | SEC Form 4 |
| Petersen Floyd F. | AMPH | Director | Feb 1 '24 | Sell | $53.64 | 26 | $1,394.64 | 80,333 | SEC Form 4 |
| Luo Mary Z. | AMPH | COO,Chief Scientist & Chairman | Jan 10 '24 | Sell | $54.32 | 78,236 | $4,249,967.29 | 1,157,566 | SEC Form 4 |
| Luo Mary Z. | AMPH | COO,Chief Scientist & Chairman | Jan 10 '24 | Sell | $54.89 | 50,514 | $2,772,506.35 | 1,107,052 | SEC Form 4 |
| Luo Mary Z. | AMPH | COO,Chief Scientist & Chairman | Jan 10 '24 | Sell | $55.95 | 920 | $51,477.13 | 1,106,132 | SEC Form 4 |
| Luo Mary Z. | AMPH | COO,Chief Scientist & Chairman | Jan 10 '24 | Sell | $57.00 | 1,716 | $97,816.98 | 1,104,416 | SEC Form 4 |
| Luo Mary Z. | AMPH | COO,Chief Scientist & Chairman | Jan 8 '24 | Sell | $56.98 | 18,858 | $1,074,562.78 | 1,436,744 | SEC Form 4 |
| Luo Mary Z. | AMPH | COO,Chief Scientist & Chairman | Jan 8 '24 | Sell | $58.25 | 41,282 | $2,404,474.22 | 1,395,462 | SEC Form 4 |
| Luo Mary Z. | AMPH | COO,Chief Scientist & Chairman | Jan 8 '24 | Sell | $59.24 | 37,865 | $2,243,141.53 | 1,357,597 | SEC Form 4 |
| Luo Mary Z. | AMPH | COO,Chief Scientist & Chairman | Jan 8 '24 | Sell | $59.99 | 27,563 | $1,653,622.89 | 1,330,034 | SEC Form 4 |
| Luo Mary Z. | AMPH | COO,Chief Scientist & Chairman | Jan 8 '24 | Sell | $61.19 | 4,261 | $260,742.09 | 1,325,773 | SEC Form 4 |
| Luo Mary Z. | AMPH | COO,Chief Scientist & Chairman | Jan 8 '24 | Sell | $61.81 | 1,663 | $102,784.04 | 1,324,110 | SEC Form 4 |
Latest Amphastar Pharmaceuticals Inc. News
AMPH Breaking Stock News: Dive into AMPH Ticker-Specific Updates for Smart Investing
Argus Research
3 days ago
AMPH: Raising target price to $43.00
Argus Research
10 days ago
AMPH: Raising target price to $42.00
Zacks
11 days ago
Why Amphastar (AMPH) is Poised to Beat Earnings Estimates Again
Zacks
16 days ago
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
Argus Research
17 days ago
AMPH: What does Argus have to say about AMPH?
Argus Research
24 days ago
AMPH: Lowering target price to $39.00
GuruFocus.com
a month ago
Insider Sale: CFO, EVP & Treasurer William Peters Sells Shares of Amphastar Pharmaceuticals ...
GuruFocus.com
a month ago
Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH)
Compare AMPH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AMPH Amphastar Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.